An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

By Stadler Walter M.   Vaughn David J.   Sonpavde Guru   Vogelzang Nicholas J.   Tagawa Scott T.   Petrylak Daniel P.   Rosen Peter   Lin Chia-Chi   Mahoney John   Modi Sanjiv   Lee Peter   Ernstoff Marc S.   Su Wu-Chou   Spira Alexander   Pilz Korinna   Vinisko Richard   Schloss Charles   Fritsch Holger   Zhao Charles   Carducci Michael A.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 976-982

Blackwell Publishing

Access to resources Recommend Favorite

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma

By Furman Wayne  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1660-1670

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility of Chemoradiotherapy for Oesophageal Cancer in Elderly Patients Aged ≥75 Years: A Prospective, Single-Arm Phase II Study

By Servagi-Vernat Stephanie  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 255-262

Adis International

Access to resources Recommend Favorite

Long-Term Assessment of Topiramate for Epilepsy: An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting

By Hufnagel Andreas  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 779-790

Adis International

Access to resources Recommend Favorite

Single-Arm Study for the Characterization of Human Tissue Response to Injectable Poly-L-Lactic Acid

By Goldberg David   Guana Adriana   Volk Andrea   Daro-Kaftan Elizabeth  

Dermatologic Surgery, Vol. 39, Iss. 6, 2013-06 ,pp. : 915-922

Elsevier

Access to resources Recommend Favorite